ACHV Achieve Life Sciences Inc
P/E
--
Forward P/E
35.34
Price/Sales
5.09
Beta
2.264
Div Yield
--
Market Cap
--
Company Analysis
Latest News
🟢 ACHV is trading 5.9% up today as it rebounds from a recent FDA setback
ACHV is trading at $5.30 (up 5.9%), continuing a recovery following a sharp decline triggered by an FDA decision last week. • The FDA recently declined to...
🟢 Achieve Life Sciences Inc makes sharp 10.1% jump
ACHV is trading at $5.34, up 10.1% versus the comparison close of $4.85 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Achieve Life Sciences Inc Rises 5.1% Following FDA Complete Response Letter for Cytisinicline NDA
• Achieve Life Sciences Inc. received a Complete Response Letter (CRL) from the FDA for its cytisinicline New Drug Application (NDA) today, June 22, 2026. •...
🔴 Achieve Life Sciences Inc drops 5% as FDA's cytisinicline decision date approaches with expected Complete Response Letter
Achieve Life Sciences Inc is trading at $5.09 (-5.04%) today. The decline comes as the Prescription Drug User Fee Act (PDUFA) date of June 20, 2026, for its...